

Doxofylline (CAS 69975-86-6) has emerged as a high-growth asset within the API intermediates market due to its superior safety profile compared to traditional methylxanthines, driving a surge in global sourcing for high purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) used in the large-scale manufacture of advanced bronchodilators for asthma and COPD. Doxophylline is increasingly central to custom synthesis services as CDMOs prioritize manufacturing processes that ensure stringent regulatory compliance and precise impurity profiling for oral solid dosage forms. Ansimar serves as a vital benchmark for any bulk chemical supplier navigating the shift toward specialized respiratory therapeutics, where maintaining consistent crystalline morphology and meeting WHO-GMP standards is essential for penetration into emerging healthcare markets. We are an established Doxofylline api supplier with >= 99% purity globally for semi-finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Doxofylline COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities

Doxofylline (CAS 69975-86-6) has emerged as a high-growth asset within the API intermediates market due to its superior safety profile compared to traditional methylxanthines, driving a surge in global sourcing for high purity fine chemicals (Pharma/API purity 99% | General Industry purity 98%) used in the large-scale manufacture of advanced bronchodilators for asthma and COPD. Doxophylline is increasingly central to custom synthesis services as CDMOs prioritize manufacturing processes that ensure stringent regulatory compliance and precise impurity profiling for oral solid dosage forms. Ansimar serves as a vital benchmark for any bulk chemical supplier navigating the shift toward specialize...

Chemical Properties & Specifications
P264, P264+P265, P270, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P332+P317, P337+P317, P362+P364, and P501
Acute Tox. 4 (100%)
Skin Irrit. 2 (33.3%)
A xanthine derivative used as a potent bronchodilator for the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD) by relaxing airway smooth muscles
A non-selective phosphodiesterase inhibitor employed in respiratory research to study its protective effects against inflammatory responses in pulmonary bronchial epithelial cells
A pharmacological compound utilized for its antitussive properties to manage and relieve cough associated with obstructive airway diseases
A therapeutic agent that exhibits anti-inflammatory activity, potentially mediated through the activation of histone deacetylases (HDAC), used to reduce airway inflammation in chronic lung conditions
A high-purity methylxanthine derivative incorporated into various drug formulations, including tablets, syrups, and injectables, for the systemic treatment of bronchospastic disorders.
Doxofylline is a xanthine derivative and bronchodilator used for the treatment and maintenance of chronic obstructive pulmonary disease (COPD) and bronchial asthma by relaxing airway smooth muscles
This compound is primarily utilized in the pharmaceutical and healthcare industries for the production of respiratory medications
It is highly soluble in water and compatible with various oral and injectable dosage forms including tablets, sustained-release matrix tablets, sublingual tablets, syrups, suspensions, and polymeric nanomicelles for inhalation
Standard specifications include high purity confirmed by melting point (144-146°C), molecular weight 266.25, and documentation such as COA, TDS, impurity reports, and regulatory compliance documents
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time
The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and specific grade.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : Calcium acetate monohydrate (CAS No: 5743-26-0) occupies a critical position in the global specialit...
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...